Financials
- Market Capitalization 1.55 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-25.35
Rapporto prezzo/fatturato
26.85
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2156 | GHRS GH Research PLC - Ordinary Shares | 25.35 USD | -4.38% | -3.17% | +19.74% | +79.03% | 1.57 B USD | ||
| 2159 | AVBP ArriVent BioPharma, Inc. - Common Stock | 33.64 USD | -0.15% | -3.03% | +9.51% | +53.40% | 1.57 B USD | ||
| 2170 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.38 USD | -15.14% | -16.07% | -7.56% | +103.02% | 1.55 B USD | ||
| 2185 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.41 USD | +0.25% | +9.14% | +8.28% | +113.49% | 1.50 B USD |